Neither shorting nor dilution has stopped the price rise.
Celldex is working toward some plan. The plan is known only to top management at this time. It's obvious though that Celldex is becoming a 900 pound gorilla. I have never seen such a well managed biotech. People thinking of selling too early should think twice. jmho